Latest & greatest articles for hypertension

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hypertension or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hypertension and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hypertension

183. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies 28053559 2018 11 13 1179-156X 9 2017 Open access rheumatology : research and reviews Open Access Rheumatol Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. 1-9 10.2147/OARRR.S123549 Systemic lupus erythematosus (SLE) is characterized by the second highest prevalence of pulmonary arterial hypertension (PAH), after systemic sclerosis (...) antagonists immunosuppressive pulmonary arterial hypertension systemic lupus erythematosus transthoracic echocardiogram The authors report no conflicts of interest in this work. 2017 1 6 6 0 2017 1 6 6 0 2017 1 6 6 1 epublish 28053559 10.2147/OARRR.S123549 oarrr-9-001 PMC5191623 Rheumatology (Oxford). 2009 Dec;48(12):1506-11 19671698 J Rheumatol. 2007 Dec;34(12):2417-22 17985403 Ann Rheum Dis. 2006 Oct;65(10):1336-40 16793845 Am J Cardiol. 1990 Aug 15;66(4):493-6 2386120 Rheumatol Int. 2012 Jun;32(6):1727

Open access rheumatology : research and reviews2016 Full Text: Link to full Text with Trip Pro

184. Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats

Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats 28462145 2018 11 13 2213-4220 6 1 2017 Mar Integrative medicine research Integr Med Res Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats. 60-65 10.1016/j.imr.2016.12.002 Glucocorticoid is among the most commonly prescribed medicine. Unfortunately, Excess glucocorticoid level leads hypertension in 80-90% patients. Garlic (Allium sativum) has been used since ancient times and even nowadays (...) as a part of popular medicine for various ailments and physiological disorders. Hence this study was undertaken to investigate the antihypertensive activity of allicin in dexamethasone induced hypertension in wistar rats. The animals were randomly divided into four groups comprising of six rats per group. Hypertension was induced by subcutaneous injection of dexamethasone (10 μg/rat/day) in hypertensive rats. Two hypertensive group animals were treated with nicorandil (6 mg/kg/day, po) and allicin (8 mg

Integrative medicine research2016 Full Text: Link to full Text with Trip Pro

185. The Use of the Ambulatory Arterial Stiffness Index in Patients Suspected of Secondary Hypertension

The Use of the Ambulatory Arterial Stiffness Index in Patients Suspected of Secondary Hypertension 28018907 2018 11 13 2297-055X 3 2016 Frontiers in cardiovascular medicine Front Cardiovasc Med The Use of the Ambulatory Arterial Stiffness Index in Patients Suspected of Secondary Hypertension. 50 10.3389/fcvm.2016.00050 The ambulatory arterial stiffness index (AASI) is a marker of arterial stiffness and is derived from ambulatory 24-h blood pressure registration. We studied whether the AASI (...) could be used as a predictive factor for the presence of renal artery stenosis (RAS) in patients with a suspicion of secondary hypertension and as such as a diagnostic tool for RAS. We included 169 patients with difficult-to-treat hypertension. They all underwent 24-h ambulatory blood pressure monitoring registration, imaging of the renal arteries, and cardiovascular risk measurement, including smoking, history, biometrics, blood pressure, renal function, lipids, and glucose metabolism. Performing

Frontiers in cardiovascular medicine2016 Full Text: Link to full Text with Trip Pro

186. Endoscopic treatment of hypertensive intracerebral hemorrhage: A technical review

Endoscopic treatment of hypertensive intracerebral hemorrhage: A technical review 29063035 2018 11 13 2095-882X 2 3 2016 Sep Chronic diseases and translational medicine Chronic Dis Transl Med Endoscopic treatment of hypertensive intracerebral hemorrhage: A technical review. 140-146 10.1016/j.cdtm.2016.11.002 Hypertensive intracerebral hemorrhage (ICH) is still a highlighting global issue. Endoscopic evacuation as a minimally invasive treatment became an alternative other than conventional (...) 26047414 Neurology. 2001 May 22;56(10 ):1294-9 11376176 Neurosurgery. 2014 Dec;75(6):E734-6 25161002 World Neurosurg. 2016 Jul;91:452-9 27132183 Thromb Haemost. 2003 Feb;89(2):278-83 12574807 Manag Care Interface. 2006 Jun;19(6):24-8, 34 16892657 Acta Neurochir Suppl. 2011;112:3-8 21691979 J Neurosurg. 2017 Feb;126(2):548-557 27104852 Stroke. 2003 Aug;34(8):2060-5 12843354 Endoscopic treatment Hematoma evacuation Hypertension Intracerebral hemorrhage (ICH) 2016 10 27 2017 10 25 6 0 2017 10 25 6 0 2017

Chronic diseases and translational medicine2016 Full Text: Link to full Text with Trip Pro

187. Subacute right heart failure revealing three simultaneous causes of post‐embolic pulmonary hypertension in metastatic dissemination of breast cancer

Subacute right heart failure revealing three simultaneous causes of post‐embolic pulmonary hypertension in metastatic dissemination of breast cancer 28217316 2018 11 13 2055-5822 4 1 2017 Feb ESC heart failure ESC Heart Fail Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer. 75-77 10.1002/ehf2.12106 A 72-year-old woman with history of breast cancer only treated surgically was referred to our (...) department for pulmonary hypertension (PH) suspicion. Echocardiogram revealed elevated right ventricular systolic pressure. Computed tomography (CT) angiogram showed no pulmonary embolism (PE), but lung scan revealed two ventilation-perfusion mismatch areas. Right cardiac catheterization established precapillary PH. Despite treatment with PH specific therapy (sildenafil, ambrisentan, and epoprostenol), her condition worsened rapidly with acute right heart failure (RHF). She died 22 days after admission

ESC heart failure2016 Full Text: Link to full Text with Trip Pro

188. Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update

Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update

CMA Infobase (Canada)2016

189. Pulmonary Arterial Hypertension Diagnosis, Treatment, and Clinical Management in the Contemporary Era

Pulmonary Arterial Hypertension Diagnosis, Treatment, and Clinical Management in the Contemporary Era 27851839 2018 11 13 2380-6591 1 9 2016 Dec 01 JAMA cardiology JAMA Cardiol Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review. 1056-1065 10.1001/jamacardio.2016.4471 Pulmonary arterial hypertension (PAH) is characterized by severe remodeling of the distal pulmonary arteries, increased pulmonary vascular resistance, and right

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

190. A putative mechanism of salt-dependent neurogenic hypertension: cell-autonomous activation of OVLT neurons by hypernatremia

A putative mechanism of salt-dependent neurogenic hypertension: cell-autonomous activation of OVLT neurons by hypernatremia 27895191 2018 01 16 2018 11 13 1524-4563 69 1 2017 01 Hypertension (Dallas, Tex. : 1979) Hypertension Putative Mechanism of Salt-Dependent Neurogenic Hypertension: Cell-Autonomous Activation of Organum Vasculosum Laminae Terminalis Neurons by Hypernatremia. 20-22 Guyenet Patrice G PG From the Department of Pharmacology, University of Virginia, Charlottesville. pgg (...) @virginia.edu. eng R01 HL028785 HL NHLBI NIH HHS United States R01 HL074011 HL NHLBI NIH HHS United States R37 HL028785 HL NHLBI NIH HHS United States Editorial Research Support, N.I.H., Extramural Comment 2016 11 28 United States Hypertension 7906255 0194-911X 0 Sodium Chloride, Dietary IM Neurosci Res. 2016 Dec;113:1-11 27521454 J Neurosci. 2011 Oct 12;31(41):14669-76 21994383 Acta Physiol (Oxf). 2015 May;214(1):8-32 25753944 Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2181-6 16766644 Clin Exp

Hypertension (Dallas, Tex. : 1979)2016 Full Text: Link to full Text with Trip Pro

191. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study

Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study 28588953 2018 11 13 2059-7908 1 3 2016 BMJ global health BMJ Glob Health Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study. e000055 10.1136/bmjgh-2016-000055 With an ageing HIV-positive population, sub-Saharan Africa is now facing a dual epidemic of communicable and non (...) -communicable diseases (NCDs). This study aimed to assess trends in the prevalence of hypertension and factors associated with hypertension, among adults attending an ambulatory HIV clinic in Kampala, Uganda. We conducted a retrospective chart review to identify patients with hypertension. We used a random number generator to select 400 patient charts from each year from 2009 to 2014. Blood pressure, age, body mass index (BMI), WHO disease stage and Karnofsky scores were extracted. Logistic regression

BMJ global health2016 Full Text: Link to full Text with Trip Pro

192. Management of mild hypertension in adults.

Management of mild hypertension in adults. Elevated blood pressure is a common risk factor for cardiovascular disease and affects one in three adults. Blood pressure lowering drugs substantially reduce the risk of stroke, coronary heart disease, heart failure, and premature death, but most clinical trials showing benefits have primarily included patients with moderate to severe hypertension, known cardiovascular disease, or elevated risk of cardiovascular disease. The benefits of treating mild (...) hypertension in patients without cardiovascular disease are less clear, but recent meta-analyses offer some insights. Pooled data from trials that include a large percentage of participants with mild hypertension show significant reductions in stroke, death from cardiovascular disease, and total mortality. Meta-analyses comparing lower blood pressure targets also suggest a benefit of treating patients with mild hypertension, although net benefits are greater for patients at higher absolute levels

BMJ2016

193. Reply to comment on coronary artery disease and hypertension in a non-selected spinal cord injury patient population (letter to the Editor)

Reply to comment on coronary artery disease and hypertension in a non-selected spinal cord injury patient population (letter to the Editor) 28053770 2018 11 13 2058-6124 2 2016 Spinal cord series and cases Spinal Cord Ser Cases Reply to comment on coronary artery disease and hypertension in a non-selected spinal cord injury patient population (letter to the Editor). 16029 10.1038/scsandc.2016.29 Aidinoff Elena E Faculty of Medicine, Department of Rehabilitation, and School of Mathematics

Spinal cord series and cases2016 Full Text: Link to full Text with Trip Pro

194. Portal hypertension: an uncommon clinical manifestation of Takayasu arteritis in a 9-year-old child

Portal hypertension: an uncommon clinical manifestation of Takayasu arteritis in a 9-year-old child 27895519 2018 11 13 1179-156X 8 2016 Open access rheumatology : research and reviews Open Access Rheumatol Portal hypertension: an uncommon clinical manifestation of Takayasu arteritis in a 9-year-old child. 115-118 Takayasu arteritis (TA) is the third most common childhood vasculitis and its clinical manifestations depend on the arteries involved. We report a case of a 9-year-old boy (...) hemorrhage. Angiography revealed enlargement of aneurysms enlargement and new aneurysms. He also developed portal hypertension. Treatment with intravenous corticosteroids, azathioprine, and monthly intravenous cyclophosphamide was begun. After 6 months of no improvement, infliximab was begun. The aim of this article was to report the concurrence of coronary involvement and portal vein hypertension in pediatric TA because there were scarce reports on this matter. Herrera Cristina N CN Department

Open access rheumatology : research and reviews2016 Full Text: Link to full Text with Trip Pro

195. Building on a Legacy of Hypertension Research: Charting Our Future Together

Building on a Legacy of Hypertension Research: Charting Our Future Together 27849567 2018 01 29 2018 11 13 1524-4563 69 1 2017 01 Hypertension (Dallas, Tex. : 1979) Hypertension Building on a Legacy of Hypertension Research: Charting Our Future Together. 5-10 Mensah George A GA From the National Heart, Lung, and Blood Institute, Bethesda, MD. Galis Zorina S ZS From the National Heart, Lung, and Blood Institute, Bethesda, MD. Fine Lawrence J LJ From the National Heart, Lung, and Blood Institute (...) , Bethesda, MD. Garcia Melissa E ME From the National Heart, Lung, and Blood Institute, Bethesda, MD. Levy Daniel F DF From the National Heart, Lung, and Blood Institute, Bethesda, MD. Gibbons Gary H GH From the National Heart, Lung, and Blood Institute, Bethesda, MD. Gary.Gibbons@nih.gov. eng Z99 HL999999 NULL Intramural NIH HHS United States Journal Article Review 2016 11 14 United States Hypertension 7906255 0194-911X IM PLoS Genet. 2015 Mar 18;11(3):e1005035 25785607 Circ Res. 2013 Apr 26;112(9):1212

Hypertension (Dallas, Tex. : 1979)2016 Full Text: Link to full Text with Trip Pro

196. Gamechanger? Is Spironolactone the Magic Bullet for Resistant Hypertension?

Gamechanger? Is Spironolactone the Magic Bullet for Resistant Hypertension? Gamechanger? Is Spironolactone the Magic Bullet for Resistant Hypertension? | Clinical Correlations Gamechanger? Is Spironolactone the Magic Bullet for Resistant Hypertension? November 9, 2016 By Amar Parikh, MD Peer Reviewed Welcome to Gamechangers, a series that takes a critical look at the latest in medical literature to answer one important question: would the results of this article change my practice? Featuring (...) thorough evidence-based review as well as expert commentary, our aim is for this series to help you decide if the results of a given study are, in fact, a gamechanger. A 65 year-old Hispanic male with type 2 diabetes, hypertension, hyperlipidemia, and erectile dysfunction presents to clinic for follow-up and is found to be hypertensive to a systolic blood pressure (SBP) in the 160s on a regimen of amlodipine 10 mg daily, lisinopril 40 mg daily, and hydrochlorothiazide 25 mg daily. The patient

Clinical Correlations2016

197. Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment

Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment 27604060 2018 09 17 2018 11 13 2380-6591 1 8 2016 11 01 JAMA cardiology JAMA Cardiol Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment. 864-871 10.1001/jamacardio.2016.2861 The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated the benefit of lowering systolic blood pressure (SBP) to 120 mm Hg, yet other trials, such as Heart Outcomes Prevention Evaluation-3 (HOPE-3), did not find (...) (12):2296-304 25259547 BMJ. 2009 May 19;338:b1665 19454737 JAMA. 2014 Feb 5;311(5):507-20 24352797 Am J Cardiol. 2013 Jul 15;112(2):266-71 23608614 J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-59 24239921 J Am Coll Cardiol. 2015 Apr 28;65(16):1633-9 25743624 N Engl J Med. 2015 Nov 26;373(22):2103-16 26551272 Hypertension. 2010 Aug;56(2):196-202 20530299 Circulation. 2007 Feb 20;115(7):846-54 17309935 JAMA. 2003 May 21;289(19):2560-72 12748199 J Am Heart Assoc. 2015 Sep 21;4(9):e002275 26391135

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

198. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease 29142956 2018 11 13 2468-0249 2 2 2017 Mar Kidney international reports Kidney Int Rep Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. 180-191 10.1016/j.ekir.2016.10.006 Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies (...) the effect of hypertension control on outcomes is unknown. We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m 2 ) in 4262 community-dwelling individuals (40% men) more than 65 years of age. At baseline, 19% had CKD, and 31.2% had controlled hypertension on ≤3 antihypertensive drugs, 62.3% uncontrolled hypertension ≥140/90 mm Hg on ≤2 drugs, and 6.5% apparent treatment-resistant hypertension (aTRH) ≥140/90 mm

Kidney international reports2016 Full Text: Link to full Text with Trip Pro

199. Sex Differences in Hypertension: Recent Advances

Sex Differences in Hypertension: Recent Advances 27777357 2018 01 26 2018 11 13 1524-4563 68 6 2016 12 Hypertension (Dallas, Tex. : 1979) Hypertension Sex Differences in Hypertension: Recent Advances. 1322-1327 Gillis Ellen E EE From the Department of Physiology, Augusta University, GA. Sullivan Jennifer C JC From the Department of Physiology, Augusta University, GA. jensullivan@augusta.edu. eng R01 HL127091 HL NHLBI NIH HHS United States Journal Article Research Support, N.I.H., Extramural (...) Review 2016 10 24 United States Hypertension 7906255 0194-911X IM Hypertension. 2015 May;65(5):1073-81 25776077 Hypertension. 2011 Mar;57(3):397-405 21263119 Hypertension. 2011 Feb;57(2):275-82 21189402 Cell Immunol. 2015 Apr;294(2):95-101 25498375 Hypertension. 2015 Aug;66(2):396-402 26056343 Nat Rev Cardiol. 2016 Mar;13(3):167-79 26525543 Hypertension. 2012 Jan;59(1):129-35 22124434 Am J Med. 2016 Oct;129(10):1030-6 27427323 J Cell Mol Med. 2015 Aug;19(8):1975-85 25991381 Hypertension. 2014 Sep;64

Hypertension (Dallas, Tex. : 1979)2016 Full Text: Link to full Text with Trip Pro

200. A rare cause of hypertension in pregnancy: Phaeochromocytoma

A rare cause of hypertension in pregnancy: Phaeochromocytoma 28680468 2018 11 13 1753-495X 10 2 2017 Jun Obstetric medicine Obstet Med A rare cause of hypertension in pregnancy: Phaeochromocytoma. 83-84 10.1177/1753495X16669995 A 26-year-old primigravida at 35 weeks' gestation was transferred to our institution from a regional hospital for management of presumed preeclampsia. Due to the labile nature of her hypertension, further investigation was undertaken which revealed a right-sided (...) phaeochromocytoma. Alpha blockade was commenced, and an uncomplicated elective caesarean delivery was performed at 38 weeks' gestation under spinal anaesthetic. The patient underwent an elective right laparoscopic adrenalectomy six weeks post-partum. This case highlights the importance of investigating young women for secondary causes of hypertension to avoid mislabelling as essential or gestational hypertension. Shah Sonali S Department of Endocrinology, Austin and Mercy Health, Melbourne, Australia. Edwards

Obstetric medicine2016 Full Text: Link to full Text with Trip Pro